Ted Nugent told UCR in a March 2025 interview why he should have gotten the call to induct the legendary Detroit band.
The madness of March showed up a little early in College Park on Wednesday. In a 55-55 game with under 10 seconds left between Michigan State and Maryland, the Terrapins rushed up the floor with a ...
After promising that "Something's Gonna Happen" on his first single in 1981, Marshall Crenshaw has delivered with a career of ...
Canadian provinces pulling US alcohol off store shelves in response to Trump trade policy is "worse than tariffs", the boss of Jack Daniel's maker Brown-Forman has said. Several Canadian provinces, ...
MANILA, Philippines — The issuance of domestic securities and the weakening of the peso pushed the country’s outstanding debt to a fresh high of P16.31 trillion in January, the Bureau of the ...
Comedian Matt Lucas has apologised to actress Millie Bobby Brown after he posted a Little Britain catchphrase alongside photographs of the 21-year-old on social media. Lucas, 50, wrote "no but ...
Free Expression: Great-power theory would relieve the U.S. of some burdens, but poses risks to the national interest Photo: Xie Huanchi/Sergei Bulkin/CNP/Zuma Press A frenzied first month of the ...
TORONTO, March 3 (Reuters) - The Canadian dollar weakened to a one-month low against its U.S. counterpart on Monday as U.S. President Donald Trump said that tariffs on Canada and Mexico will go ...
Scientists believe a new era of warming has already begun. That may not sound like much, but a 5-degree rise will affect almost every aspect of human life, in ways both large and small. What will ...
The pedestrian did remain stable, police said. SEE ALSO: 2 killed in fiery crash after Tesla hits Woodridge house, bursts into flames: police Glenview police and the North Regional Major Crimes ...
On Monday, Warren Buffett's Berkshire Hathaway (NYSE:BRK, BRK.B)) pulled ahead of Elon Musk's Tesla (NASDAQ:TSLA) in market value, showing just how much earnings matter in the stock market.
An experimental medicine from Protagonist Therapeutics stabilized red blood cells and improved symptoms in patients with a rare blood cancer — achieving the efficacy goals of a Phase 3 study.